Question · asked by 1 review

CLOZAPINE + RISPERIDONE vs CLOZAPINE + SULPIRIDE (Kong 2001): Quality of life/satisfaction with care for either recipients of care or carers: significant change in quality of life/satisfaction

Population
people with treatment‐resistant schizophrenia
Intervention
CLOZAPINE + RISPERIDONE
Comparison
CLOZAPINE + SULPIRIDE (Kong 2001)
Outcome
Quality of life/satisfaction with care for either recipients of care or carers: significant change in quality of life/satisfaction

The review found no eligible studies for this question.

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
CLOZAPINE + RISPERIDONE vs CLOZAPINE + SULPIRIDE (Kong 2001)
Quality of life/satisfaction with care for either recipients of care or carers: significant change in quality of life/satisfaction · people with treatment‐resistant schizophrenia
The review found no eligible studies for this question.
Clozapine combined with different antipsychotic drugs for treatment‐resistant schizophrenia (2017) · Cochrane Headline outcomes only
no estimate extractedNot reportedNo studies found

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Clozapine combined with different antipsychotic drugs for treatment‐resistant schizophrenia
2017 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.